» Articles » PMID: 32821115

CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis Via Altering of MiR-508-3p/CXCL13 Signal

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Aug 22
PMID 32821115
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Accumulating evidence has demonstrated that circular RNAs (circRNAs) play a key role in the tumorigenesis of various types of cancers, including clear cell renal cell carcinoma (ccRCC).

Materials And Methods: Reverse transcription-quantitative polymerase chain reaction was used to detect the expression of circRNA homeodomain interacting protein kinase 3 (circHIPK3) and microRNAs (miRNAs), including miR-508-3p. The clinical measurement of circHIPK3 was evaluated by Kaplan-Meier survival analysis and receiver operating characteristic analysis. Cell Counting Kit-8 and Transwell chamber assays were performed to determine the changes in the proliferative and metastatic ability of A498 and 786-O cells. C-X-C motif chemokine ligand 13 (CXCL13) protein expression was detected by Western blot analysis. The targeted binding effect between miR-508-3p and circHIPK3 or CXCL13 was confirmed by constructed luciferase and RNA immunoprecipitation (RIP) assays, respectively. Fluorescence in situ hybridization (FISH) assay was used to measure the subcellular localization of circHIPK3 and miR-508-3p.

Results: It was found that circHIPK3 was markedly upregulated in ccRCC tissue and cell lines, and circHIPK3-upregulation was closely correlated with poor clinicopathological features in patients with ccRCC. It was found that both miR-508-3p and circHIPK3 were localized in the cytoplasm of ccRCC cells. The up- and downregulation of circHIPK3 positively regulated ccRCC cell proliferation and metastasis, and this regulatory effect was reversed by miR-508-3p. Through luciferase and RIP assays, it was confirmed that circHIPK3 could interacted with miR-508-3p. Furthermore, it was revealed that CXCL13, which was negatively correlated with miR-508-3p, was upregulated in ccRCC. It was also shown that CXCL13 was a downstream target of miR-508-3p. miR-508-3p suppressed ccRCC cell proliferation and metastasis by targeting CXCL13. Lastly, it was demonstrated that circHIPK3 promoted CXCL13 to facilitate ccRCC cell proliferation and metastasis by decoying miR-508-3p.

Conclusion: In brief, the results of the present study showed that circHIPK3 promoted ccRCC cell proliferation and metastasis by altering miR-5083p/CXCL13 signaling. The present findings might provide a novel target for the molecular treatment of ccRCC.

Citing Articles

The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach.

Campelo M, Reis-das-Merces L, Vidal A, da Silva F, de Oliveira A, Monteiro J Front Oncol. 2025; 15:1547889.

PMID: 40061896 PMC: 11885226. DOI: 10.3389/fonc.2025.1547889.


HAS-CIRCpedia-5280 sponges miR-4712-5p inhibited colon cancer autophagyinduced by human beta-defensin-1.

An S, Cui J, Yang W, Zhang M, Yu H, Lu J J Transl Med. 2025; 23(1):281.

PMID: 40050987 PMC: 11883960. DOI: 10.1186/s12967-024-05860-x.


Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study.

Golestanifar A, Khedri H, Noorabadi P, Saberiyan M Biochem Biophys Rep. 2025; 41:101942.

PMID: 39980583 PMC: 11840516. DOI: 10.1016/j.bbrep.2025.101942.


The prognosis of ciRS-7 and circHIPK3 in pan-cancer: a mini-review and meta-analysis.

Li X, Wu T, Dong R, Wu X Discov Oncol. 2025; 16(1):207.

PMID: 39969753 PMC: 11839969. DOI: 10.1007/s12672-025-01944-2.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


References
1.
Ma C, Qin J, Zhang J, Wang X, Wu D, Li X . Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma. Mol Med Rep. 2019; 21(1):141-150. PMC: 6896406. DOI: 10.3892/mmr.2019.10811. View

2.
Zheng Z, Cai Y, Chen H, Chen Z, Zhu D, Zhong Q . CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma. Front Oncol. 2019; 8:682. PMC: 6349755. DOI: 10.3389/fonc.2018.00682. View

3.
Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C . circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019; 10(1):3200. PMC: 6642174. DOI: 10.1038/s41467-019-11162-4. View

4.
Wang Z, Jin J . LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis. Aging (Albany NY). 2019; 11(14):4876-4889. PMC: 6682525. DOI: 10.18632/aging.102081. View

5.
Vishnoi A, Rani S . MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol. 2016; 1509:1-10. DOI: 10.1007/978-1-4939-6524-3_1. View